Cytokine production and proliferation upon in vitro oligodeoxyribonucleotide stimulation of equine peripheral blood mononuclear cells

Veterinary Immunology and Immunopathology

Volumn 146, Issue 2, 2012, Pages 113-124

  Wattrang, Eva ^a   Palm, Anna Karin ^b,d   Wagner, Bettina ^c  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c Cornell University ^*  (United States)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cytokines; Horse; Oligodeoxyribonucleotides; PBMC; Proliferation

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; CYTOSINE; GAMMA INTERFERON; GUANOSINE; INTERFERON; LIPOFECTIN; OLIGODEOXYRIBONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE 1; OLIGODEOXYRIBONUCLEOTIDE 2; OLIGODEOXYRIBONUCLEOTIDE 2006; OLIGODEOXYRIBONUCLEOTIDE 2395; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CPG ISLAND; CYTOKINE PRODUCTION; HORSE; LEUKOCYTE FUNCTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT;

ANIMALS; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSES; INTERFERON TYPE I; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; OLIGODEOXYRIBONUCLEOTIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EQUIDAE;

EID: 84859494418     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.02.004     Document Type: Article

References (70)

1. Abel K., Wang Y., Fritts L., Sanchez E., Chung E., Fitzgerald-Bocarsly P., Krieg A.M., Miller C.J. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells. Clin Diagn Lab Immunol 2005, 12:606-621.
2. Agrawal S., Kandimalla E.R. Synthetic agonists of Toll-like receptors 7, 8 and 9. Biochem Soc Trans 2007, 35:1461-1467.
3. Agrawal S., Temsamani J., Galbraith W., Tang J. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995, 28:7-16.
4. Bartz H., Mendoza Y., Gebker M., Fischborn T., Heeg K., Dalpke A. Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes. Vaccine 2004, 23:148-155.
5. Bauer S., Kirschning C.J., Häcker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001, 98:9237-9242.
6. Bauer S., Pigisch S., Hangel D., Kaufmann A., Hamm S. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9. Immunobiology 2008, 213:315-328.
7. Bennett C.F., Chiang M.Y., Chan H., Shoemaker J.E., Mirabelli C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992, 41:1023-1033.
8. Bernard M.P., Phipps R.P. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol 2007, 125:138-148.
9. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
10. Booth J.S., Nichani A.K., Benjamin P., Dar A., Krieg A.M., Babiuk L.A., Mutwiri G.K. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells. Vet Immunol Immunopathol 2007, 115:24-34.
11. Chen J., Xu W., Zhou T., Ding Y., Duan J., Huang F. Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development. Parasite Immunol 2009, 31:466-473.
12. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
13. Cho J.Y., Miller M., Baek K.J., Han J.W., Nayar J., Rodriguez M., Lee S.Y., McElwain K., McElwain S., Raz E., Broide D.H. Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. Am J Respir Cell Mol Biol 2004, 30:651-661.
14. Costa L.T., Kerkmann M., Hartmann G., Endres S., Bisch P.M., Heckl W.M., Thalhammer S. Structural studies of oligonucleotides containing G-quadruplex motifs using AFM. Biochem Biophys Res Commun 2004, 313:1065-1072.
15. Crosby L., Casey W., Morgan K., Ni H., Yoon L., Easton M., Misukonis M., Burleson G., Ghosh D.K. Murine J774 macrophages recognize LPS/IFN-g, non-CpG DNA or two-CpG DNA-containing sequences as immunologically distinct. Nitric Oxide 2010, 22:242-257.
16. Danielpour D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J Immunol Methods 1993, 158:17-25.
17. Danielpour D., Kim K.Y., Dart L.L., Watanabe S., Roberts A.B., Sporn M.B. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 1989, 2:61-71.
18. Desjardins I., Theoret C., Joubert P., Wagner B., Lavoie J.P. Comparison of TGF-beta 1 concentrations in bronchoalveolar fluid of horses affected with heaves and of normal controls. Vet Immunol Immunopathol 2004, 101:133-141.
19. Di J.M., Pang J., Pu X.Y., Zhang Y., Liu X.P., Fang Y.Q., Ruan X.X., Gao X. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet 2009, 192:60-67.
20. Di Paolo S., Schena A., Stallone G., Grandaliano G., Soccio M., Cerullo G., Gesualdo L., Paolo Schena F. Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition?. A study in cyclosporine-treated kidney-transplanted patients. Transplantation 2002, 74:1710-1715.
21. Domeika K., Magnusson M., Eloranta M.L., Fuxler L., Alm G.V., Fossum C. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet Immunol Immunopathol 2004, 101:87-102.
22. Elias F., Flo J., Lopez R.A., Zorzopulos J., Montaner A., Rodriguez J.M. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J Immunol 2003, 171:3697-3704.
23. Flaminio M.J., Borges A.S., Nydam D.V., Horohov D.W., Hecker R., Matychak M.B. The effect of CpG-ODN on antigen presenting cells of the foal. J Immune Based Ther Vaccines 2007, 5:1.
24. Guiducci C., Ott G., Chan J.H., Damon E., Calacsan C., Matray T., Lee K.D., Coffman R.L., Barrat F.J. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 2006, 203:1999-2008.
25. Guzylack-Piriou L., Balmelli C., McCullough K.C., Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 2004, 112:28-37.
26. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., Wagner H. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 2008, 28:315-323.
27. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003, 33:1633-1641.
28. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol 2000, 164:1617-1624.
29. He H., Crippen T.L., Farnell M.B., Kogut M.H. Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev Comp Immunol 2003, 27:621-627.
30. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
31. Ishii K.J., Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol 2006, 27:525-532.
32. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001, 31:3388-3393.
33. Jensen-Waern M., Persson S.G., Nordengrahn A., Merza M., Fossum C. Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity. Acta Vet Scand 1998, 39:25-33.
34. Jurk M., Schulte B., Kritzler A., Noll B., Uhlmann E., Wader T., Schetter C., Krieg A.M., Vollmer J. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 2004, 209:141-154.
35. Kamstrup S., Verthelyi D., Klinman D.M. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet Microbiol 2001, 78:353-362.
36. Kato A., Homma T., Batchelor J., Hashimoto N., Imai S., Wakiguchi H., Saito H., Matsumoto K. Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol 2003, 4:8.
37. Kerkmann M., Costa L.T., Richter C., Rothenfusser S., Battiany J., Hornung V., Johnson J., Englert S., Ketterer T., Heckl W., Thalhammer S., Endres S., Hartmann G. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J Biol Chem 2005, 280:8086-8093.
38. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 2003, 170:4465-4474.
39. Klier J., May A., Fuchs S., Schillinger U., Plank C., Winter G., Gehlen H., Coester C. Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles. Vet Immunol Immunopathol 2011, 144:79-87.
40. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004, 4:249-258.
41. Korpinen E., Groop P.H., Fagerudd J.A., Teppo A.M., åkerblom H.K., Vaarala O. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy. Diabet Med 2001, 18:121-125.
42. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709-760.
43. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006, 5:471-484.
44. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001, 31:2154-2163.
45. Land C.E. Confidence interval estimation for means after data transformation to normality. J Am Stat Assoc 1974, 69:795-802.
46. Leise B.S., Yin C., Pettigrew A., Belknap J.K. Proinflammatory cytokine responses of cultured equine keratinocytes to bacterial pathogen-associated molecular pattern motifs. Equine Vet J 2010, 42:294-303.
47. Liu M., Liu T., Bordin A., Nerren J., Cohen N. Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi. Cytokine 2009, 48:280-289.
48. Liu T., Nerren J., Liu M., Martens R., Cohen N. Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals. Vaccine 2009, 27:674-683.
49. Lopez A.M., Hecker R., Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A., Townsend H.G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet Immunol Immunopathol 2006, 114:103-110.
50. Lugo-Villarino G., Ito S., Klinman D.M., Glimcher L.H. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc Natl Acad Sci USA 2005, 102:13248-13253.
51. Magnusson M., Johansson E., Berg M., Eloranta M.L., Fuxler L., Fossum C. The plasmid pcDNA3 differentially induces production of interferon-alpha and interleukin-6 in cultures of porcine leukocytes. Vet Immunol Immunopathol 2001, 78:45-56.
52. Marshall J.D., Heeke D.S., Abbate C., Yee P., Van Nest G. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha. Immunology 2006, 117:38-46.
53. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+regulatory T cells. J Immunol 2004, 173:4433-4442.
54. Nicolson L., McMonagle L., Taylor S., Hopkins C., Sanders L., van Kuilekom H., Scholtes N., Argyle D., Onions D., Schijns V. Equine cytokines and associated reagents. Equine immunology in 2001 2001, 57-58. R & W Publications Limited, Newmarket. D.P. Lunn, J.F. Wade (Eds.).
55. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001, 11:333-340.
56. Roberts T.L., Sweet M.J., Hume D.A., Stacey K.J. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J Immunol 2005, 174:605-608.
57. Rothenfusser S., Hornung V., Krug A., Towarowski A., Krieg A.M., Endres S., Hartmann G. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol 2001, 31:3525-3534.
58. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
59. Thierry A.R., Dritschilo A. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res 1992, 20:5691-5698.
60. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., Fitzgerald K.A., Paludan S.R., Bowie A.G. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
61. Wagner B., Hillegas J.M., Flaminio M., Wattrang E. Monoclonal antibodies to equine interferon-α (IFN-α): new tools to neutralize IFN activity and to detect secreted IFN-α. Vet Immunol Immunopathol 2008, 125:315-325.
62. Wagner B., Robeson J., McCracken M., Wattrang E., Antczak D.F. Horse cytokine/IgG fusion proteins-mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Vet Immunol Immunopathol 2005, 105:1-14.
63. Wagner H. The sweetness of the DNA backbone drives Toll-like receptor 9. Curr Opin Immunol 2008, 20:396-400.
64. Wattrang E., Berg M., Magnusson M. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. Vet Immunol Immunopathol 2005, 107:265-279.
65. Wikström F.H., Meehan B.M., Berg M., Timmusk S., Elving J., Fuxler L., Magnusson M., Allan G.M., McNeilly F., Fossum C. Structure-dependent modulation of alpha interferon production by porcine circovirus 2 oligodeoxyribonucleotide and CpG DNAs in porcine peripheral blood mononuclear cells. J Virol 2007, 81:4919-4927.
66. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 2004, 34:251-262.
67. Vollmer J., Weeratna R.D., Jurk M., Samulowitz U., McCluskie M.J., Payette P., Davis H.L., Schetter C., Krieg A.M. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 2004, 113:212-223.
68. Xu Y., Szoka F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996, 35:5616-5623.
69. Yu D., Putta M.R., Bhagat L., Dai M., Wang D., Trombino A.F., Sullivan T., Kandimalla E.R., Agrawal S. Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction. Antimicrob Agents Chemother 2008, 52:4320-4325.
70. Zhang Y.W., Davis E.G., Blecha F., Wilkerson M.J. Molecular cloning and characterization of equine Toll-like receptor 9. Vet Immunol Immunopathol 2008, 124:209-219.